Company Filing History:
Years Active: 2020
Title: Chi-Li Ni: Innovator in Pharmaceutical Chemistry
Introduction
Chi-Li Ni is a prominent inventor based in Evanston, Illinois. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical biochemical pathways.
Latest Patents
Chi-Li Ni holds a patent for "3-carbon substituted 4-aminocyclopent-1-ene-1-carboxylic acid compounds as inhibitors of gamma-aminobutyric acid (GABA) aminotransferase." This patent discloses cyclopentene compounds that serve as inhibitors of GABA aminotransferase and ornithine aminotransferase. The compounds may be formulated into pharmaceutical compositions aimed at treating diseases and disorders associated with GABA-AT and OAT activity, including epilepsy, addiction, and hepatocellular carcinoma.
Career Highlights
Chi-Li Ni is affiliated with Northwestern University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating various neurological and metabolic disorders.
Collaborations
Chi-Li Ni has collaborated with notable colleagues, including Richard B. Silverman and Jose Juncosa, enhancing the scope and depth of her research initiatives.
Conclusion
Chi-Li Ni's innovative work in pharmaceutical chemistry exemplifies the vital role of inventors in advancing medical science. Her contributions are paving the way for new treatments that could significantly improve patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.